Inventor · disambiguated record
Hanshermann Franke
Also filed as: FRANKE HANSHERMANN
4 granted patents·5 pending applications·6 citations·filing 1995–2021
62Inventor score
Files withLTS LOHMANN THERAPIE SYSTEME AG4LOHMANN THERAPIE SYST LTS2DESITIN ARZNEIMITTEL GMBH1FRANKE HANSHERMANN1
Top patents by PatentIndex Score
9 records- 0172US2021287764A1System for determining a suitability of an active ingredient to be applied transdermally or transmucosally and corresponding methodLTS LOHMANN THERAPIE SYSTEME AG·Filed 2021·Application pending·0 cites
- 0258US11744806B2Frigostable composition for iontophoretic transdermal delivery of a triptan compoundLTS LOHMANN THERAPIE SYSTEME AG·Filed 2018·Granted Sep 5, 2023·0 cites·22 claims
- 0349US11464760B2Frigostable composition for iontophoretic transdermal delivery of a triptan compoundLTS LOHMANN THERAPIE SYSTEME AG·Filed 2018·Granted Oct 11, 2022·0 cites·14 claims
- 0444US2017046504A1System for determining a suitability of an active ingredient to be applied transdermally or transmucosally and corresponding methodLTS LOHMANN THERAPIE SYSTEME AG·Filed 2015·Application pending·0 cites
- 0543US2004142033A1Pharmaceutical composition, containing oxcarbazepine with sustained release of an active-ingredientDESITIN ARZNEIMITTEL GMBH·Filed 2003·Application pending·0 cites
- 0640US2004185095A1Pharmaceutical composition containing oxcarbazepine and having a controlled active substance releaseFiled 2003·Application pending·0 cites
- 0737US5932239ATransdermal therapeutic system with protection against hydrolysisLOHMANN THERAPIE SYST LTS·Filed 1995·Granted Aug 3, 1999·5 cites·20 claims
- 0832US2007232528A1Formulation comprising histone deacetylase inhibitorsFRANKE HANSHERMANN·Filed 2005·Application pending·0 cites
- 0931US6630149B1Blister containing a transdermal therapeutic system and a single dose form of administrationLOHMANN THERAPIE SYST LTS·Filed 1999·Granted Oct 7, 2003·1 cites·10 claims
Join the waitlist — get patent alerts
Get an alert when Hanshermann Franke files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →